Export

You can select particular sections to be included in the output file.
EN
FR

Model List of Essential Medicines

clear Found 75 recommendations for 17 medicines and 2 therapeutic equivalents
Removed medicines and rejected applications are not shown. Show them.
6.2.2. Watch group antibiotics
  1. Azithromycin General information
    Section
    Watch group antibiotics
    • Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
    • Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)
    Indications
    First choice
    Trachoma Cholera Cholera [children] Paratyphoid fever Chlamydia trachomatis Typhoid fever Yaws co-prescribed with ceftriaxone Gonococcal infection
    Second choice
    Infectious gastroenteritis or colitis without specification of infectious agent co-prescribed with cefixime Gonococcal infection
  2. Cefixime General information
    Section
    Watch group antibiotics
    • Oral > Liquid: 100 mg per 5 mL powder for oral liquid
    • Oral > Solid: 200 mg (as trihydrate); 400 mg (as trihydrate)
    Indications
    Second choice
    Infectious gastroenteritis or colitis without specification of infectious agent Gonococcal infection
  3. Cefotaxime General information
    Section
    Watch group antibiotics
    • Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
    Indications
    First choice
    Bacterial meningitis Inflammatory and other diseases of prostate (severe) Acute pyelonephritis (severe) Bacterial pneumonia (Community-acquired pneumonia - severe) [children] Bacterial pneumonia (Community-acquired pneumonia - severe) Peritoneal abscess (mild-moderate) Peritoneal abscess (severe) Other specified pneumonia (Hospital-acquired pneumonia) Peritonitis (mild-moderate) Peritonitis (severe)
    Second choice
    Inflammatory and other diseases of prostate (mild to moderate) Acute pyelonephritis (mild to moderate) Sepsis without septic shock Bacterial infection of joint Osteomyelitis or osteitis
  4. Ceftazidime General information
    Section
    Watch group antibiotics
    • Parenteral > General injections > unspecified: 250 mg in vial (as pentahydrate) powder for injection; 1 g in vial (as pentahydrate) powder for injection
    Indications
    First choice
    Endophthalmitis
    Other indications
    Pseudomonas aeruginosa resistant to other antibiotic
  5. Ceftriaxone General information
    Section
    Watch group antibiotics
    • Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
    • Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
    • Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
    • Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial
    Indications
    First choice
    Inflammatory and other diseases of prostate (severe) Bacterial meningitis Acute pyelonephritis (severe) Other specified pneumonia (Hospital-acquired pneumonia) Paratyphoid fever Typhoid fever Peritonitis (mild-moderate) Peritonitis (severe) Peritoneal abscess (mild-moderate) Peritoneal abscess (severe) Gonococcal infection Endophthalmitis Bacterial pneumonia (Community-acquired pneumonia - severe) Bacterial pneumonia (Community-acquired pneumonia - severe) [children] co-prescribed with metronidazole Necrotising fasciitis
    Second choice
    Inflammatory and other diseases of prostate (mild to moderate) Acute pyelonephritis (mild to moderate) Infectious gastroenteritis or colitis without specification of infectious agent Bacterial infection of joint Sepsis without septic shock Osteomyelitis or osteitis
  6. Cefuroxime General information
    Section
    Watch group antibiotics
    • Parenteral > General injections > IV: 250 mg in vial (as sodium salt) powder for injection; 750 mg in vial (as sodium salt) powder for injection; 1.5 g in vial (as sodium salt) powder for injection
    Indications
    Second choice
    Other specified prophylactic measures
  7. Ciprofloxacin General information
    Section
    Watch group antibiotics
    • Parenteral > General injections > IV: 2 mg per mL (as hyclate)
    • Oral > Liquid: 250 mg per 5 mL (anhydrous)
    • Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
    • Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)
    Indications
    First choice
    Acute pyelonephritis (mild to moderate) Infectious gastroenteritis or colitis without specification of infectious agent Paratyphoid fever Typhoid fever Neutropenia (low-risk) Inflammatory and other diseases of prostate (mild to moderate)
    Second choice
    Cholera Cholera [children] Peritonitis (mild-moderate) Peritoneal abscess (mild-moderate)
  8. Clarithromycin General information
    Section
    Watch group antibiotics
    • Oral > Liquid: 125 mg per 5 mL powder for oral liquid; 250 mg per 5 mL powder for oral liquid
    • Parenteral > General injections > unspecified: 500 mg in vial powder for injection
    • Oral > Solid > dosage form: 500 mg; 250 mg
    • Oral > Solid > dosage form: 500 mg
    Indications
    First choice
    co-prescribed with cefotaxime Bacterial pneumonia (Community-acquired pneumonia - severe) co-prescribed with ceftriaxone Bacterial pneumonia (Community-acquired pneumonia - severe)
    Second choice
    Acute pharyngitis co-prescribed with amoxicillin + clavulanic acid Bacterial pneumonia (Community-acquired pneumonia - severe)
    Other indications
    Helicobacter pylori associated gastric ulcer
  9. Erythromycin General information
    Section
    Watch group antibiotics
    Indications
    Second choice
    Therapeutic equivalent to clarithromycin for Acute pharyngitis
  10. Imipenem + cilastatin General information
    Section
    Watch group antibiotics
    Indications
    Second choice
    Therapeutic equivalent to meropenem for Peritonitis (severe) Therapeutic equivalent to meropenem for Peritoneal abscess (severe) Therapeutic equivalent to meropenem for Neutropenia (high-risk)
  11. Meropenem General information
    Section
    Watch group antibiotics
    • Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection
    Indications
    Second choice
    Neonatal meningitis Peritonitis (severe) Peritoneal abscess (severe) Neutropenia (high-risk)
  12. Piperacillin + tazobactam General information
    Section
    Watch group antibiotics
    • Parenteral > General injections > IV: 2 g (as sodium salt) + 250 mg (as sodium salt) powder for injection; 4 g (as sodium salt) + 500 mg (as sodium salt) powder for injection
    Indications
    First choice
    Neutropenia (high-risk) Other specified pneumonia (Hospital-acquired pneumonia) Peritonitis (severe) Peritoneal abscess (severe) co-prescribed with clindamycin Necrotising fasciitis
  13. Vancomycin General information
    Section
    Watch group antibiotics
    • Oral > Solid > capsule: 125 mg (as hydrochloride); 250 mg (as hydrochloride)
    • Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection
    • Parenteral > Locoregional injections > Intravitreal: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection
    Indications
    First choice
    Necrotising fasciitis co-prescribed with ceftazidime Endophthalmitis co-prescribed with ceftriaxone Endophthalmitis
    Second choice
    Intestinal infections due to Clostridioides difficile Neutropenia (high-risk)